Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
TheFly reported on May 15 that Maxim Group reduced its price target on LUCD from $3 to $2 while maintaining a Buy rating following a weaker-than-expected first-quarter revenue report.


